JEREMY NIVENS: Open Payments
NPI 1780896431 · PLAINFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,945 in 196 payments from 19 companies in 2025. Trend: 2023 $2,571 · 2024 $3,087 · 2025 $2,945
Food & beverage: $2,804Education: $141
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 39 | $556 |
| ABBVIE INC. | 32 | $420 |
| Janssen Biotech, Inc. | 18 | $313 |
| Galderma Laboratories, L.P. | 28 | $305 |
| Regeneron Healthcare Solutions, Inc. | 23 | $240 |
| Novartis Pharmaceuticals Corporation | 12 | $217 |
| Incyte Corporation | 7 | $160 |
| GENZYME CORPORATION | 8 | $156 |
| UCB, Inc. | 7 | $138 |
| Amgen Inc. | 5 | $102 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, ILUMYA, Winlevi, SKYRIZI, OPZELURA.
Industry payments across IN — which companies pay providers there.
